APA
Santella J. B., Gardner D. S., Yao W., Shi C., Reddy P., Tebben A. J., DeLucca G. V., Wacker D. A., Watson P. S., Welch P. K., Wadman E. A., Davies P., Solomon K. A., Graden D. M., Yeleswaram S., Mandlekar S., Kariv I., Decicco C. P., Ko S. S., Carter P. H. & Duncia J. V. (20080527). From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: the discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis. : Bioorganic & medicinal chemistry letters.
Chicago
Santella Joseph B, Gardner Daniel S, Yao Wenqing, Shi Chongsheng, Reddy Prabhakar, Tebben Andrew J, DeLucca George V, Wacker Dean A, Watson Paul S, Welch Patricia K, Wadman Eric A, Davies Paul, Solomon Kimberly A, Graden Dani M, Yeleswaram Swamy, Mandlekar Sandhya, Kariv Ilona, Decicco Carl P, Ko Soo S, Carter Percy H and Duncia John V. 20080527. From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: the discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis. : Bioorganic & medicinal chemistry letters.
Harvard
Santella J. B., Gardner D. S., Yao W., Shi C., Reddy P., Tebben A. J., DeLucca G. V., Wacker D. A., Watson P. S., Welch P. K., Wadman E. A., Davies P., Solomon K. A., Graden D. M., Yeleswaram S., Mandlekar S., Kariv I., Decicco C. P., Ko S. S., Carter P. H. and Duncia J. V. (20080527). From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: the discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis. : Bioorganic & medicinal chemistry letters.
MLA
Santella Joseph B, Gardner Daniel S, Yao Wenqing, Shi Chongsheng, Reddy Prabhakar, Tebben Andrew J, DeLucca George V, Wacker Dean A, Watson Paul S, Welch Patricia K, Wadman Eric A, Davies Paul, Solomon Kimberly A, Graden Dani M, Yeleswaram Swamy, Mandlekar Sandhya, Kariv Ilona, Decicco Carl P, Ko Soo S, Carter Percy H and Duncia John V. From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: the discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis. : Bioorganic & medicinal chemistry letters. 20080527.